Stressed to death: Targeting endoplasmic reticulum stress response induced apoptosis in gliomas

Current Pharmaceutical Design

Volumn 17, Issue 3, 2011, Pages 284-292

  Johnson, Guyla G ^a   White, Misti C ^a   Grimaldi, Maurizio ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Calcium; Caspase 4 12; Endoplasmic reticulum stress response; Glioma; Gliotoxicity; Small molecules

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; ATAZANAVIR; BREFELDIN A; CALCIUM; CASPASE 12; CASPASE 3; CASPASE 4; CASPASE 7; CELECOXIB; CURCUMIN; CYCLOOXYGENASE 2 INHIBITOR; FLAVONOID; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NELFINAVIR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEASOME INHIBITOR; PROTEIN IRE1; SESQUITERPENE; STRESS ACTIVATED PROTEIN KINASE; THAP; TUNICAMYCIN; UBIQUITIN; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CELLULAR STRESS RESPONSE; DRUG TARGETING; DRUG TOLERABILITY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME INHIBITION; GLIOMA; GLYCOSYLATION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING;

ADULT; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; GLIOMA; HUMANS; MICE; MOLECULAR TARGETED THERAPY;

EID: 79958235988     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211795049660     Document Type: Article

References (112)

1. Hegi, M.E., et al., MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med, 2005. 352(10): p. 997-1003.
2. Furnari, F.B., et al., Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev, 2007. 21(21): p. 2683-710.
3. Schroder, M. and R.J. Kaufman, ER stress and the unfolded proteinresponse. Mutat Res, 2005. 569(1-2): p. 29-63.
4. Rao, R.V., H.M. Ellerby, and D.E. Bredesen, Coupling endoplasmicreticulum stress to the cell death program. Cell Death Differ, 2004.11(4): p. 372-80.
5. Chevalier, M., et al., Interaction of murine BiP/GRP78 with the DnaJ homologue MTJ1. J Biol Chem, 2000. 275(26): p. 19620-7.
6. Li, J. and A.S. Lee, Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med, 2006. 6(1): p. 45-54.
7. Freiden, P.J., J.R. Gaut, and L.M. Hendershot, Interconversion of three differentially modified and assembled forms of BiP. Embo J,1992. 11(1): p. 63-70.
8. Hendershot, L.M., J. Ting, and A.S. Lee, Identity of the immunoglobulinheavy-chain-binding protein with the 78,000-dalton glucose-regulated protein and the role of posttranslational modificationsin its binding function. Mol Cell Biol, 1988. 8(10): p. 4250-6.
9. Laitusis, A.L., M.A. Brostrom, and C.O. Brostrom, The dynamicrole of GRP78/BiP in the coordination of mRNA translation withprotein processing. J Biol Chem, 1999. 274(1): p. 486-93.
10. Shen, J., et al., ER stress regulation of ATF6 localization by dissociationof BiP/GRP78 binding and unmasking of Golgi localizationsignals. Dev Cell, 2002. 3(1): p. 99-111.
11. Ye, J., et al., ER stress induces cleavage of membrane-bound ATF6by the same proteases that process SREBPs. Mol Cell, 2000. 6(6):p. 1355-64.
12. Haze, K., et al., Mammalian transcription factor ATF6 is synthesizedas a transmembrane protein and activated by proteolysis inresponse to endoplasmic reticulum stress. Mol Biol Cell, 1999.10(11): p. 3787-99.
13. Yoshida, H., et al., Identification of the cis-acting endoplasmicreticulum stress response element responsible for transcriptionalinduction of mammalian glucose-regulated proteins. Involvement ofbasic leucine zipper transcription factors. J Biol Chem, 1998.273(50): p. 33741-9.
14. Okada, T., et al., Distinct roles of activating transcription factor 6(ATF6) and double-stranded RNA-activated protein kinase-like endoplasmicreticulum kinase (PERK) in transcription during them ammalian unfolded protein response. Biochem J, 2002. 366(Pt 2):p. 585-94.
15. Lee, A.H., N.N. Iwakoshi, and L.H. Glimcher, XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol, 2003. 23(21): p. 7448-59.
16. Wu, J., et al., ATF6alpha optimizes long-term endoplasmic reticulumfunction to protect cells from chronic stress. Dev Cell, 2007.13(3): p. 351-64.
17. Kim, I., W. Xu, and J.C. Reed, Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov, 2008. 7(12): p. 1013-30.
18. Tirasophon, W., et al., The endoribonuclease activity of mammalianIRE1 autoregulates its mRNA and is required for the unfolded proteinresponse. Genes Dev, 2000. 14(21): p. 2725-36.
19. Yoshida, H., et al., XBP1 mRNA is induced by ATF6 and spliced byIRE1 in response to ER stress to produce a highly active transcriptionfactor. Cell, 2001. 107(7): p. 881-91.
20. Lee, K., et al., IRE1-mediated unconventional mRNA splicing andS2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev, 2002. 16(4): p. 452-66.
21. Sood, R., et al., Pancreatic eukaryotic initiation factor-2alphakinase (PEK) homologues in humans, Drosophila melanogaster and Caenorhabditis elegans that mediate translational control in response to endoplasmic reticulum stress. Biochem J, 2000. 346 Pt 2:p. 281-93.
22. Bertolotti, A., et al., Dynamic interaction of BiP and ER stresstransducers in the unfolded-protein response. Nat Cell Biol, 2000.2(6): p. 326-32.
23. Prostko, C.R., et al., Phosphorylation of eukaryotic initiation factor(eIF) 2 alpha and inhibition of eIF-2B in GH3 pituitary cells byperturbants of early protein processing that induce GRP78. J BiolChem, 1992. 267(24): p. 16751-4.
24. Harding, H.P., et al., Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell,2000. 6(5): p. 1099-108.
25. Luo, S., et al., Induction of Grp78/BiP by translational block: activationof the Grp78 promoter by ATF4 through and upstream ATF/CRE site independent of the endoplasmic reticulum stress elements. J Biol Chem, 2003. 278(39): p. 37375-85.
26. Harding, H.P., et al., An integrated stress response regulates aminoacid metabolism and resistance to oxidative stress. Mol Cell, 2003.11(3): p. 619-33.
27. Jiang, H.Y., et al., Phosphorylation of the alpha subunit of eukaryoticinitiation factor 2 is required for activation of NF-kappaB inresponse to diverse cellular stresses. Mol Cell Biol, 2003. 23(16):p. 5651-63.
28. Wang, C.Y., et al., NF-kappaB induces expression of the Bcl-2homologue A1/Bfl-1 to preferentially suppress chemotherapyinducedapoptosis. Mol Cell Biol, 1999. 19(9): p. 5923-9.
29. Healy, S.J., et al., Targeting the endoplasmic reticulum-stress response as an anticancer strategy. Eur J Pharmacol, 2009. 625(1-3):p. 234-46.
30. Schroder, M. and R.J. Kaufman, The mammalian unfolded proteinresponse. Annu Rev Biochem, 2005. 74: p. 739-89.
31. Oyadomari, S. and M. Mori, Roles of CHOP/GADD153 in endoplasmicreticulum stress. Cell Death Differ, 2004. 11(4): p. 381-9.
32. Ma, Y., et al., Two distinct stress signaling pathways convergeupon the CHOP promoter during the mammalian unfolded proteinresponse. J Mol Biol, 2002. 318(5): p. 1351-65.
33. Wang, X.Z., et al., Cloning of mammalian Ire1 reveals diversity in the ER stress responses. Embo J, 1998. 17(19): p. 5708-17.
34. Yoshida, H., et al., ATF6 activated by proteolysis binds in the presenceof NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol Cell Biol, 2000.20(18): p. 6755-67.
35. Oyadomari, S., et al., Nitric oxide-induced apoptosis in pancreaticbeta cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci U S A, 2001. 98(19): p. 10845-50.
36. McCullough, K.D., et al., Gadd153 sensitizes cells to endoplasmicreticulum stress by down-regulating Bcl2 and perturbing the cellularredox state. Mol Cell Biol, 2001. 21(4): p. 1249-59.
37. Ma, Y. and L.M. Hendershot, The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer,2004. 4(12): p. 966-77.
38. Puthalakath, H., et al., ER stress triggers apoptosis by activatingBH3-only protein Bim. Cell, 2007. 129(7): p. 1337-49.
39. Yamaguchi, H. and H.G. Wang, CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression inhuman carcinoma cells. J Biol Chem, 2004. 279(44): p. 45495-502.
40. Thastrup, O., et al., Thapsigargin, a tumor promoter, dischargesintracellular Ca2+ stores by specific inhibition of the endoplasmicreticulum Ca2(+)-ATPase. Proc Natl Acad Sci U S A, 1990. 87(7):p. 2466-70.
41. Jiang, C.C., et al., Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis. Cancer Res, 2007. 67(20): p. 9750-61.
42. Rao, R.V., et al., Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett, 2002.514(2-3): p. 122-8.
43. Nakagawa, T. and J. Yuan, Cross-talk between two cysteine proteasefamilies. Activation of caspase-12 by calpain in apoptosis. JCell Biol, 2000. 150(4): p. 887-94.
44. Imaizumi, K., T. Katayama, and M. Tohyama, Presenilin and the UPR. Nat Cell Biol, 2001. 3(5): p. E104.
45. Rao, R.V., et al., Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem,2001. 276(36): p. 33869-74.
46. Nakagawa, T., et al., Caspase-12 mediates endoplasmic-reticulumspecificapoptosis and cytotoxicity by amyloid-beta. Nature, 2000.403(6765): p. 98-103.
47. Rao, R.V., et al., Coupling endoplasmic reticulum stress to the celldeath program. An Apaf-1-independent intrinsic pathway. J Biol Chem, 2002. 277(24): p. 21836-42.
48. Fischer, H., et al., Human caspase 12 has acquired deleteriousmutations. Biochem Biophys Res Commun, 2002. 293(2): p. 722-6.
49. Hitomi, J., et al., Involvement of caspase-4 in endoplasmic reticulumstress-induced apoptosis and Abeta-induced cell death. J CellBiol, 2004. 165(3): p. 347-56.
50. Matsuzaki, S., et al., Caspase-4 is partially cleaved by calpain viathe impairment of Ca2+ homeostasis under the ER stress. NeurochemInt, 2010. 56(2): p. 352-6.
51. Kardosh, A., et al., Aggravated endoplasmic reticulum stress as abasis for enhanced glioblastoma cell killing by bortezomib in combinationwith celecoxib or its non-coxib analogue, 2,5-dimethylcelecoxib.Cancer Res, 2008. 68(3): p. 843-51.
52. Pyrko, P., et al., HIV-1 protease inhibitors nelfinavir and atazanavirinduce malignant glioma death by triggering endoplasmicreticulum stress. Cancer Res, 2007. 67(22): p. 10920-8.
53. Pyrko, P., et al., The unfolded protein response regulatorGRP78/BiP as a novel target for increasing chemosensitivity in malignantgliomas. Cancer Res, 2007. 67(20): p. 9809-16.
54. Tan, Y., et al., Ubiquitous calpains promote caspase-12 and JNKactivation during endoplasmic reticulum stress-induced apoptosis. JBiol Chem, 2006. 281(23): p. 16016-24.
55. Nishitoh, H., et al., ASK1 is essential for JNK/SAPK activation byTRAF2. Mol Cell, 1998. 2(3): p. 389-95.
56. Urano, F., et al., Coupling of stress in the ER to activation of JNKprotein kinases by transmembrane protein kinase IRE1. Science,2000. 287(5453): p. 664-6.
57. Hetz, C., et al., The proapoptotic BCL-2 family member BIM mediates motoneuron loss in a model of amyotrophic lateral sclerosis. Cell Death Differ, 2007. 14(7): p. 1386-9.
58. Lei, K. and R.J. Davis, JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A, 2003. 100(5): p. 2432-7.
59. Yamamoto, K., H. Ichijo, and S.J. Korsmeyer, BCL-2 is phosphorylatedand inactivated by an ASK1/Jun N-terminal protein kinasepathway normally activated at G(2)/M. Mol Cell Biol, 1999.19(12): p. 8469-78.
60. Nishitoh, H., et al., ASK1 is essential for endoplasmic reticulumstress-induced neuronal cell death triggered by expanded polyglutaminerepeats. Genes Dev, 2002. 16(11): p. 1345-55.
61. Kim, I., et al., Chemical biology investigation of cell death pathwaysactivated by endoplasmic reticulum stress reveals cytoprotectivemodulators of ASK1. J Biol Chem, 2009. 284(3): p. 1593-603.
62. Auf, G., et al., Inositol-requiring enzyme 1alpha is a key regulatorof angiogenesis and invasion in malignant glioma. Proc Natl AcadSci U S A, 2010. 107(35): p. 15553-8.
63. Warburg, O., On the origin of cancer cells. Science, 1956.123(3191): p. 309-14.
64. Luo, J., N.L. Solimini, and S.J. Elledge, Principles of cancer therapy:oncogene and non-oncogene addiction. Cell, 2009. 136(5): p.823-37.
65. Hsiao, J.R., et al., Endoplasmic reticulum stress triggers XBP-1-mediated up-regulation of an EBV oncoprotein in nasopharyngealcarcinoma. Cancer Res, 2009. 69(10): p. 4461-7.
66. Schonthal, A.H., Endoplasmic reticulum stress and autophagy astargets for cancer therapy. Cancer Lett, 2009. 275(2): p. 163-9.
67. Dong, D., et al., Critical role of the stress chaperone GRP78/BiP intumor proliferation, survival, and tumor angiogenesis in transgeneinducedmammary tumor development. Cancer Res, 2008. 68(2): p.498-505.
68. Wang, X.Z., et al., Signals from the stressed endoplasmic reticuluminduce C/EBP-homologous protein (CHOP/GADD153). Mol Cell Biol, 1996. 16(8): p. 4273-80.
69. Lee, A.S., GRP78 induction in cancer: therapeutic and prognosticimplications. Cancer Res, 2007. 67(8): p. 3496-9.
70. Doroudgar, S., et al., Ischemia activates the ATF6 branch of the endoplasmic reticulum stress response. J Biol Chem, 2009.284(43): p. 29735-45.
71. Romero-Ramirez, L., et al., XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res,2004. 64(17): p. 5943-7.
72. Romero-Ramirez, L., et al., X box-binding protein 1 regulates angiogenesisin human pancreatic adenocarcinomas. Transl Oncol,2009. 2(1): p. 31-8.
73. Drogat, B., et al., IRE1 signaling is essential for ischemia-inducedvascular endothelial growth factor-A expression and contributes toangiogenesis and tumor growth in vivo. Cancer Res, 2007. 67(14):p. 6700-7.
74. Fels, D.R. and C. Koumenis, The PERK/eIF2alpha/ATF4 module ofthe UPR in hypoxia resistance and tumor growth. Cancer Biol Ther,2006. 5(7): p. 723-8.
75. Blais, J.D., et al., Perk-dependent translational regulation promotestumor cell adaptation and angiogenesis in response to hypoxicstress. Mol Cell Biol, 2006. 26(24): p. 9517-32.
76. Koomagi, R., J. Mattern, and M. Volm, Glucose-related protein(GRP78) and its relationship to the drug-resistance proteins P170,GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas.Anticancer Res, 1999. 19(5B): p. 4333-6.
77. Dong, D., et al., Vascular targeting and antiangiogenesis agentsinduce drug resistance effector GRP78 within the tumor microenvironment.Cancer Res, 2005. 65(13): p. 5785-91.
78. Bilmen, J.G., et al., Inhibition of the SERCA Ca2+ pumps by curcumin.Curcumin putatively stabilizes the interaction between thenucleotide-binding and phosphorylation domains in the absence ofATP. Eur J Biochem, 2001. 268(23): p. 6318-27.
79. Das, A., N.L. Banik, and S.K. Ray, Flavonoids activated caspasesfor apoptosis in human glioblastoma T98G and U87MG cells butnot in human normal astrocytes. Cancer, 2010. 116(1): p. 164-76.
80. Ermakova, S.P., et al., (-)-Epigallocatechin gallate over comes resistance to etoposideinduced cell death by targeting the molecularchaperone glucose-regulated protein 78. Cancer Res, 2006.66(18): p. 9260-9.
81. Johnson, A.J., et al., The cyclo-oxygenase-2 inhibitor celecoxibperturbs intracellular calcium by inhibiting endoplasmic reticulumCa2+-ATPases: a plausible link with its antitumour effect and cardiovascular risks. Biochem J, 2002. 366(Pt 3): p. 831-7.
82. Pyrko, P., et al., Calcium-activated endoplasmic reticulum stress asa major component of tumor cell death induced by 2,5-dimethylcelecoxib,a non-coxib analogue of celecoxib. Mol Cancer Ther,2007. 6(4): p. 1262-75.
83. Berridge, M.J., The endoplasmic reticulum: a multifunctional signaling organelle. Cell Calcium, 2002. 32(5-6): p. 235-49.
84. Flourakis, M., et al., Passive calcium leak via translocon is a first step for iPLA2-pathway regulated store operated channels activation. Faseb J, 2006. 20(8): p. 1215-7.
85. Hajnoczky, G., E. Davies, and M. Madesh, Calcium signaling andapoptosis. Biochem Biophys Res Commun, 2003. 304(3): p. 445-54.
86. Van Coppenolle, F., et al., Ribosome-translocon complex mediatescalcium leakage from endoplasmic reticulum stores. J Cell Sci,2004. 117(Pt 18): p. 4135-42.
87. Michalak, M., J.M. Robert Parker, and M. Opas, Ca2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium, 2002. 32(5-6): p. 269-78.
88. Thastrup, O., et al., Thapsigargin, a novel molecular probe forstudying intracellular calcium release and storage. Agents Actions,1989. 27(1-2): p. 17-23.
89. Hakii, H., et al., Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoterin two-stage mouse skin carcinogenesis. J Cancer Res Clin Oncol,1986. 111(3): p. 177-81.
90. Denmeade, S.R. and J.T. Isaacs, The SERCA pump as a the rapeutictarget: making a smart bomb for prostate cancer. Cancer BiolTher, 2005. 4(1): p. 14-22.
91. Denmeade, S.R., et al., Prostate-specific antigen-activated thapsigarginprodrug as targeted therapy for prostate cancer. J Natl CancerInst, 2003. 95(13): p. 990-1000.
92. Furuya, Y., et al., The role of calcium, pH, and cell proliferation inthe programmed (apoptotic) death of androgen-independentprostatic cancer cells induced by thapsigargin. Cancer Res, 1994.54(23): p. 6167-75.
93. Wu, S.H., et al., Curcumin induces apoptosis in human nonsmall cell lung cancer NCI-H460 cells through ER stress and caspasecascade- and mitochondria-dependent pathways. Anticancer Res,2010. 30(6): p. 2125-33.
94. Karmakar, S., N.L. Banik, and S.K. Ray, Curcumin suppressedanti-apoptotic signals and activated cysteine proteases for apoptosisin human malignant glioblastoma U87MG cells. NeurochemRes, 2007. 32(12): p. 2103-13.
95. Purkayastha, S., et al., Curcumin Blocks Brain Tumor Formation. Brain Res, 2009.
96. Contessa, J.N., et al., Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. Cancer Res, 2008.68(10): p. 3803-9.
97. Contessa, J.N., et al., Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy. Clin Cancer Res, 2010. 16(12): p. 3205-14.
98. Wong, A.J., et al., Increased expression of the epidermal growthfactor receptor gene in malignant gliomas is invariably associatedwith gene amplification. Proc Natl Acad Sci U S A, 1987. 84(19): p.6899-903.
99. Lippincott-Schwartz, J., et al., Rapid redistribution of Golgi proteinsinto the ER in cells treated with brefeldin A: evidence formembrane cycling from Golgi to ER. Cell, 1989. 56(5): p. 801-13.
100. Klausner, R.D., J.G. Donaldson, and J. Lippincott-Schwartz, BrefeldinA: insights into the control of membrane traffic and organellestructure. J Cell Biol, 1992. 116(5): p. 1071-80.
101. Lippincott-Schwartz, J., et al., Brefeldin A's effects on endosomes,lysosomes, and the TGN suggest a general mechanism for regulatingorganelle structure and membrane traffic. Cell, 1991. 67(3): p.601-16.
102. Pommepuy, I., et al., Brefeldin A induces apoptosis and cell cycleblockade in glioblastoma cell lines. Oncology, 2003. 64(4): p. 459-67.
103. Nakada, M., et al., Roles of membrane type 1 matrix metalloproteinaseand tissue inhibitor of metalloproteinases 2 in invasion anddissemination of human malignant glioma. J Neurosurg, 2001.94(3): p. 464-73.
104. Proulx-Bonneau, S., J. Pratt, and B. Annabi, A role for MT1-MMPas a cell death sensor/effector through the regulation of endoplasmicreticulum stress in U87 glioblastoma cells. J Neurooncol, 2010.
105. Hosokawa, N., et al., A novel ER alpha-mannosidase-like proteinaccelerates ER-associated degradation. EMBO Rep, 2001. 2(5): p.415-22.
106. Molinari, M., et al., Role of EDEM in the release of misfolded glycoproteinsfrom the calnexin cycle. Science, 2003. 299(5611): p.1397-400.
107. Oda, Y., et al., EDEM as an acceptor of terminally misfolded glycoproteinsreleased from calnexin. Science, 2003. 299(5611): p.1394-7.
108. Yoshida, H., et al., A time-dependent phase shift in the mammalianunfolded protein response. Dev Cell, 2003. 4(2): p. 265-71.
109. Ciechanover, A., The ubiquitin-proteasome proteolytic pathway.Cell, 1994. 79(1): p. 13-21.
110. Yin, D., et al., Proteasome inhibitor PS-341 causes cell growtharrest and apoptosis in human glioblastoma multiforme (GBM).Oncogene, 2005. 24(3): p. 344-54.
111. Friedman, H.S., T. Kerby, and H. Calvert, Temozolomide and treatment of malignant glioma. Clin Cancer Res, 2000. 6(7): p.2585-97.
112. Kubicek, G.J., et al., Phase I trial using protea some inhibitor bortezomib and concurrent temozolomide and radiotherapy for centralnervous system malignancies. Int J Radiat Oncol Biol Phys, 2009.74(2): p. 433-9.